Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty

INTRODUCTION: Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of endothelial nitric oxide synthase. Asymmetric dimethylarginine may influence the process of restenosis after coronary angioplasty. The aim of the study was to determine if initial plasma ADMA level could predi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Derkacz, Arkadiusz, Protasiewicz, Marcin, Poręba, Rafał, Doroszko, Adrian, Poręba, Małgorzata, Antonowicz-Juchniewicz, Jolanta, Andrzejak, Ryszard, Szuba, Andrzej
Médium: Artigo
Jazyk:Inglês
Vydáno: Termedia Publishing House 2011
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3258748/
https://ncbi.nlm.nih.gov/pubmed/22295027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2011.23410
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky